Fonseca R - Search Results

1

Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study.

Kumar S, Dispenzieri A, Bhutani D, Gertz M, Wechalekar A, Palladini G, Comenzo R, Fonseca R, Jaccard A, Kastritis E, Schönland S, la Porte C, Pei H, Tran N, Merlini G. Kumar S, et al. Among authors: fonseca r. Amyloid. 2023 Sep;30(3):268-278. doi: 10.1080/13506129.2022.2164488. Epub 2023 Feb 13. Amyloid. 2023. PMID: 36779691 Clinical Trial.

2

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: fonseca r. Leukemia. 1999 Mar;13(3):469-72. doi: 10.1038/sj.leu.2401336. Leukemia. 1999. PMID: 10086738

3

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: fonseca r. J Clin Oncol. 1999 May;17(5):1551-7. doi: 10.1200/JCO.1999.17.5.1551. J Clin Oncol. 1999. PMID: 10334543

4

Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.

Rajkumar SV, Fonseca R, Dewald GW, Therneau TM, Lacy MQ, Kyle RA, Greipp PR, Gertz MA. Rajkumar SV, et al. Among authors: fonseca r. Cancer Genet Cytogenet. 1999 Aug;113(1):73-7. doi: 10.1016/s0165-4608(99)00009-6. Cancer Genet Cytogenet. 1999. PMID: 10459351

5

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.

Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Rajkumar S, et al. Among authors: fonseca r. Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943. Bone Marrow Transplant. 1999. PMID: 10482933

6

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

7

Waldenström's macroglobulinemia.

Gertz MA, Fonseca R, Rajkumar SV. Gertz MA, et al. Among authors: fonseca r. Oncologist. 2000;5(1):63-7. doi: 10.1634/theoncologist.5-1-63. Oncologist. 2000. PMID: 10706651 Free article. Review.

8

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.

Schop RF, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA, Greipp PR, Rajkumar SV, Gertz MA, Lust JA, Lacy MQ, Dispenzieri A, Witzig TE, Fonseca R. Schop RF, et al. Among authors: fonseca r. Cancer Genet Cytogenet. 2002 Jan 1;132(1):55-60. doi: 10.1016/s0165-4608(01)00526-x. Cancer Genet Cytogenet. 2002. PMID: 11801310

9

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.

Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR. Rajkumar SV, et al. Among authors: fonseca r. Clin Cancer Res. 2002 Jul;8(7):2210-6. Clin Cancer Res. 2002. PMID: 12114422

10

Genomic abnormalities in monoclonal gammopathy of undetermined significance.

Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW. Fonseca R, et al. Blood. 2002 Aug 15;100(4):1417-24. Blood. 2002. PMID: 12149226 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,439 results

Search Page